High glucose production contributes to fed and fasted hyperglycemia in Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D). The breakdown of the adiponectin signaling pathway in T1D and the reduction of circulating adiponectin in T2D contribute to this abnormal increase in glucose production. Sufficient amounts of insulin could compensate for the loss of adiponectin signaling in T1D and T2D and reduce hyperglycemia. However, the combination of low adiponectin signaling and high insulin resembles an insulin resistance state associated with cardiovascular disease and decreased life expectancy. Future development of medications that correct the deficiency of adiponectin signaling in the liver could restore the metabolic balance in T1D and T2D and ...
Adiponectin is a protein hormone that modulates glucose metabolism and fatty acid oxidation. Weexplo...
Adiponectin is a protein hormone that modulates glucose metabolism and fatty acid oxidation. Weexplo...
Type 2 diabetes is a growing concern. The World Health Organisation predicts a 114% increase by 2030...
High glucose production contributes to fed and fasted hyperglycemia in Type 1 Diabetes (T1D) and Typ...
Adiponectin is a hormone that lowers glucose production by increasing liver insulin sensitivity. Ins...
Adiponectin is a hormone that lowers glucose production by increasing liver insulin sensitivity. Ins...
Adiponectin is a recently described adipokine that has been recognized as a key regulator of insulin...
Over the past 20 years, the worldwide toll of diabetes has tripled to more than 400 million, which m...
The epidemic of type 2 diabetes and impaired glucose tolerance is one of the main causes of morbidit...
In the liver, adiponectin regulates both glucose and lipid metabolism and exerts an insulin-sensitiz...
Type 2 diabetes is associated with insulin resistance, impaired pancreatic β-cell insulin secretion,...
In the liver, adiponectin regulates both glucose and lipid metabolism and exerts an insulin-sensitiz...
Unsuppressed hepatic glucose production (HGP) contributes substantially to glucose intolerance and d...
Among the adipokines, adiponectin is the first one to be described just over a decade ago. It is pro...
Adiponectin is a protein hormone that modulates glucose metabolism and fatty acid oxidation. Weexplo...
Adiponectin is a protein hormone that modulates glucose metabolism and fatty acid oxidation. Weexplo...
Adiponectin is a protein hormone that modulates glucose metabolism and fatty acid oxidation. Weexplo...
Type 2 diabetes is a growing concern. The World Health Organisation predicts a 114% increase by 2030...
High glucose production contributes to fed and fasted hyperglycemia in Type 1 Diabetes (T1D) and Typ...
Adiponectin is a hormone that lowers glucose production by increasing liver insulin sensitivity. Ins...
Adiponectin is a hormone that lowers glucose production by increasing liver insulin sensitivity. Ins...
Adiponectin is a recently described adipokine that has been recognized as a key regulator of insulin...
Over the past 20 years, the worldwide toll of diabetes has tripled to more than 400 million, which m...
The epidemic of type 2 diabetes and impaired glucose tolerance is one of the main causes of morbidit...
In the liver, adiponectin regulates both glucose and lipid metabolism and exerts an insulin-sensitiz...
Type 2 diabetes is associated with insulin resistance, impaired pancreatic β-cell insulin secretion,...
In the liver, adiponectin regulates both glucose and lipid metabolism and exerts an insulin-sensitiz...
Unsuppressed hepatic glucose production (HGP) contributes substantially to glucose intolerance and d...
Among the adipokines, adiponectin is the first one to be described just over a decade ago. It is pro...
Adiponectin is a protein hormone that modulates glucose metabolism and fatty acid oxidation. Weexplo...
Adiponectin is a protein hormone that modulates glucose metabolism and fatty acid oxidation. Weexplo...
Adiponectin is a protein hormone that modulates glucose metabolism and fatty acid oxidation. Weexplo...
Type 2 diabetes is a growing concern. The World Health Organisation predicts a 114% increase by 2030...